Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.
- NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_assertion description "[Together these data suggest quizartinib, with its unique combination of selectivity and potent/sustained inhibition of FLT3, may provide a safe and effective treatment against FLT3-driven leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.
- NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_assertion evidence source_evidence_literature NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.
- NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_assertion SIO_000772 23412931 NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.
- NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_assertion wasDerivedFrom befree-2016 NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.
- NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_assertion wasGeneratedBy ECO_0000203 NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.
- befree-2016 importedOn "2016-02-19" NP1053277.RAHsbhvcJ-S06_zgN8KrrSayQkoH30ksB0TlljeLUNgYk130_provenance.